Comparison of the Efficacy of Pirfenidone and Nintedanib in the Treatment of Patients with Idiopathic Pulmonary Fibrosis—A Single-Center Experience

<i>Background and Objectives:</i> Idiopathic pulmonary fibrosis (IPF) is a progressive, unpredictable, fatal interstitial lung disease. Antifibrotic therapy with pirfenidone or nintedanib slows functional decline, yet comparative real-world evidence remains limited. <i>Materials and Methods:</i> Thi...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Nikola Trboljevac, Sanja Dimic-Janjic, Milica Kontic, Maja Omcikus, Branislav Ilic, Filip Markovic, Anka Postic, Lidija Isovic, Mihailo Stjepanovic, Dragana Nenezic
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2026-01-01
Serie:	Medicina
Soggetti:	idiopathic pulmonary fibrosis progression real-world cohort usual interstitial pneumonia antifibrotic treatment comparison
Accesso online:	https://www.mdpi.com/1648-9144/62/1/229
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!